An analysis of research grants allocated to researchers by the Smoking Science Research Foundation funded by Japan Tobacco Inc. in 2018
-
Published:2024-07-26
Issue:July
Volume:10
Page:1-3
-
ISSN:2459-3087
-
Container-title:Tobacco Prevention & Cessation
-
language:
-
Short-container-title:Tob. Prev. Cessation
Author:
Shiga Rintaro,
Nakagawasai Shingo,
Hashimoto Eishin,
Cho Insu,
Saito Hiroaki,
Ozaki AkihikoORCID,
Tanimoto Tetsuya,
Ando Shigeaki,
Shimmura Hiroaki,
Saito Michiya,
Tabuchi Takahiro
Publisher
European Publishing
Reference6 articles.
1. 1. GBD 2019 Tobacco Collaborators. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study. Lancet. 2021;397(10292):2337-2360. doi:10.1016/S0140-6736(21)01169-7
2. Watts C, Burton S, Freeman B. 'The last line of marketing': Covert tobacco marketing tactics as revealed by former tobacco industry employees. Glob Public Health. 2021;16(7):1000-1013. doi:10.1080/17441692.2020.1824005
3. Iida K, Proctor RN. 'The industry must be inconspicuous': Japan Tobacco's corruption of science and health policy via the Smoking Research Foundation. Tob Control. Published online February 4, 2018. doi:10.1136/tobaccocontrol-2017-053971
4. Murayama A, Kamamoto S, Saito H, et al. Characteristics and Distribution of Scholarship Donations From Pharmaceutical Companies to Japanese Healthcare Institutions in 2017: A Cross-sectional Analysis. Int J Health Policy Manag. 2023;12:7621. doi:10.34172/ijhpm.2023.7621
5. Ozaki A, Saito H, Onoue Y, et al. Pharmaceutical payments to certified oncology specialists in Japan in 2016: a retrospective observational cross-sectional analysis. BMJ Open. 2019;9(9):e028805. doi:10.1136/bmjopen-2018-028805